Ab interno supraciliary microstent surgery for open angle glaucoma

Cochrane Database of Systematic Reviews

Volumn 2017, Issue 9, 2017, Pages

  Sandhu, Amanjeet ^a   Jayaram, Hari ^a   Hu, Kuang ^a   Bunce, Catey ^b   Gazzard, Gus ^a  

^a MOORFIELDS EYE HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AB INTERNO SUPRACILIARY MICROSTENT SURGERY; ARTICLE; CLINICAL EFFECTIVENESS; EYE SURGERY; HUMAN; INTERMETHOD COMPARISON; INTRAOCULAR PRESSURE; LASER SURGERY; OPEN ANGLE GLAUCOMA; OPHTHALMOLOGICAL THERAPEUTIC DEVICE; PHACOEMULSIFICATION; PRIORITY JOURNAL; SAFETY; SURGICAL DRAINAGE; SURGICAL TECHNIQUE; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 85029551986     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD012802     Document Type: Article

References (31)

1. AGIS. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. American Journal of Ophthalmology 2000;130(4):429-40.
2. Burr JM, Mowatt G, Hernandez R, Siddiqui MA, Cook J, Lourenco T, et al. The clinical effectiveness and cost-effectiveness of screening for open angle glaucoma: a systematic review and economic evaluation. Health Technology Assessment 2007;11(41):1-190.
3. CNTG Study Group. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. American Journal of Ophthalmology 1998;126(4):487-97.
4. Veritas Health Innovation. Covidence. Melbourne: Veritas Health Innovation, 2015.
5. Francis BA, Singh K, Lin SC, Hodapp E, Jampel HD, Samples JR, et al. Novel glaucoma procedures: a report by the American Academy of Ophthalmology. Ophthalmology 2011;118(7):1466-80.
6. Friedman DS, Okeke CO, Jampel HD, Ying GS, Plyler RJ, Jiang Y, et al. Risk factors for poor adherence to eyedrops in electronically monitored patients with glaucoma. Ophthalmology 2009;116(6):1097-105.
7. Gedde SJ, Herndon LW, Brandt JD, Budenz DL, Feuer WJ, Schiffman JC, et al. Postoperative complications in the Tube Versus Trabeculectomy (TVT) study during five years of follow-up. American Journal of Ophthalmology 2012;153(5):804-14.
8. Glanville JM, Lefebvre C, Miles JN, Camosso-Stefinovic J. How to identify randomized controlled trials in MEDLINE: ten years on. Journal of the Medical Library Association 2006;94(2):130-6.
9. GRADE Working Group, McMaster University. GRADEpro GDT. Version accessed prior to 13 September 2017. Hamilton (ON): GRADE Working Group, McMaster University, 2014.
10. Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B, Hussein M, et al. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Archives of Ophthalmology 2002;120(10):1268-79.
11. Higgins JP, Altman DG, Sterne JAC, editor(s). Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
12. Hu K, Gazzard G, Bunce C, Wormald R. Ab interno trabecular bypass surgery with Trabectome for open angle glaucoma. Cochrane Database of Systematic Reviews 2016, Issue 8. [DOI: 10.1002/14651858.CD011693.pub2]
13. Ismail R, Azuara-Blanco A, Ramsay CR. Outcome measures in glaucoma: a systematic review of Cochrane reviews and protocols. Journal of Glaucoma 2015;24(7):533-8.
14. Ismail R, Azuara-Blanco A, Ramsay CR. Consensus on outcome measures for glaucoma effectiveness trials: results from a delphi and nominal group technique approaches. Journal of Glaucoma 2016;25(6):539-46.
15. James Lind Alliance Sight Loss, Vision Priority Setting Partnership. Setting priorities for eye research. www.sightlosspsp.org.uk (accessed prior to 13 September 2017).
16. Kass MA, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Archives of Ophthalmology 2002;120(6):701-13.
17. King A, Azuara-Blanco A, Tuulonen A. Glaucoma. BMJ 2013;346:f3518.
18. King AJ, Hu K, Nikita E, Mulvaney CA, Azuara-Blanco A, Stead R. Subconjunctival draining minimally-invasive glaucoma devices for medically uncontrolled glaucoma. Cochrane Database of Systematic Reviews 2017, Issue 8. [DOI: 10.1002/14651858.CD012742]
19. Kirwan JF, Lockwood AJ, Shah P, Macleod A, Broadway DC, King AJ, et al. Trabeculectomy in the 21st century: a multicenter analysis. Ophthalmology 2013;120(12):2532-9.
20. Le JT, Bicket AK, Li T. Ab interno trabecular bypass surgery with iStent for open angle glaucoma. Cochrane Database of Systematic Reviews 2017, Issue 8. [DOI: 10.1002/14651858.CD012743]
21. Lichter PR, Musch DC, Gillespie BW, Guire KE, Janz NK, Wren PA, et al. Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology 2001;108(11):1943-53.
22. Mansberger SL, Gordon MO, Jampel H, Bhorade A, Brandt JD, Wilson B, et al. Reduction in intraocular pressure after cataract extraction: the Ocular Hypertension Treatment Study. Ophthalmology 2012;119(9):1826-31.
23. Okeke CO, Quigley HA, Jampel HD, Ying GS, Plyler RJ, Jiang Y, et al. Adherence with topical glaucoma medication monitored electronically. The Travatan Dosing Aid study. Ophthalmology 2009;116(2):191-9.
24. Otarola F, Hu K, Gazzard G, Bunce C. Ab interno trabecular bypass surgery with Schlemḿs Canal Microstent (Hydrus) for open angle glaucoma. Cochrane Database of Systematic Reviews 2017, Issue 8. [DOI: 10.1002/14651858.CD012740]
25. Peters D, Bengtsson B, Heijl A. Lifetime risk of blindness in open-angle glaucoma. American Journal of Ophthalmology 2013;156(4):724-30.
26. Piltz J, Gross R, Shin DH, Beiser JA, Dorr DA, Kass MA, et al. Contralateral effect of topical beta-adrenergic antagonists in initial one-eyed trials in the ocular hypertension treatment study. American Journal of Ophthalmology 2000;130(4):441-53.
27. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. British Journal of Ophthalmology 2006;90(3):262-7.
28. Radcliffe NM, Musch DC, Niziol LM, Liebmann JM, Ritch R, Collaborative Initial Glaucoma Treatment Study Group. The effect of trabeculectomy on intraocular pressure of the untreated fellow eye in the collaborative initial glaucoma treatment study. Ophthalmology 2010;117(11):2055-60.
29. Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
30. Toris CB, Yablonski ME, Wang YL, Camras CB. Aqueous humor dynamics in the aging human eye. American Journal of Ophthalmology 1999;127(4):407-12.
31. Tóth M, Hu K, Bunce C, Gazzard G. Endoscopic cyclophotocoagulation (ECP) for open angle glaucoma and primary angle closure. Cochrane Database of Systematic Reviews 2017, Issue 8. [DOI: 10.1002/14651858.CD012741]